The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| OGN | -51.31% | N/A | N/A | -74% |
| S&P | +15.57% | +80.16% | +12.49% | +65% |
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
High-yielding stocks may be tantalizing, but they often come with risks.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $1.51B | -5.3% |
| Gross Profit | $759.00M | -15.3% |
| Gross Margin | 50.36% | -5.9% |
| Market Cap | $1.86B | -51.5% |
| Market Cap / Employee | $186.41K | 0.0% |
| Employees | 10K | 0.0% |
| Net Income | -$205,000.00K | -288.1% |
| EBITDA | $324.00M | -14.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $574.00M | -15.0% |
| Accounts Receivable | $1.33B | -2.0% |
| Inventory | 1.4K | 6.4% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $8.74B | -2.5% |
| Short Term Debt | $56.00M | -12.5% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 1.44% | -5.4% |
| Return On Invested Capital | 18.05% | -7.1% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $96.00M | -71.3% |
| Operating Free Cash Flow | $141.00M | -63.8% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 5.15 | 3.60 | 5.55 | 10.01 | 123.55% |
| Price to Book | 8.13 | 4.61 | 3.79 | 2.06 | -73.60% |
| Price to Sales | 0.62 | 0.40 | 0.44 | 0.30 | -50.44% |
| Price to Tangible Book Value | -0.68 | -0.45 | -0.52 | -0.36 | -53.77% |
| Price to Free Cash Flow TTM | 8.11 | 5.87 | 4.50 | 4.15 | -50.07% |
| Enterprise Value to EBITDA | 30.06 | 26.06 | 24.31 | 31.15 | -3.29% |
| Free Cash Flow Yield | 12.3% | 17.0% | 22.2% | 24.1% | 100.29% |
| Return on Equity | 254.2% | 159.6% | 71.6% | 30.6% | -92.89% |
| Total Debt | $8.96B | $8.90B | $8.83B | $8.80B | -2.61% |
No podcast episodes available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
